Rapid identification of clinical yeast isolates using the colorimetric AUXACOLOR system

Diagnostic Microbiology and Infectious Disease

Volumn 36, Issue 2, 2000, Pages 137-138

  Romney, Marc G ^a   Bryce, Elizabeth A ^a   Rennie, Robert P ^b   Sand, Crystal A ^b  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ISOLATE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; COLORIMETRY; CONTROLLED STUDY; FUNGUS IDENTIFICATION; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; YEAST;

ANTIBIOTICS, ANTIFUNGAL; CARBOHYDRATE METABOLISM; COLONY COUNT, MICROBIAL; COLORIMETRY; CYCLOHEXIMIDE; DRUG RESISTANCE, MICROBIAL; HUMANS; MONOPHENOL MONOOXYGENASE; REAGENT KITS, DIAGNOSTIC; YEASTS;

EID: 0033955342     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00115-7     Document Type: Article

References (12)

1. Bannerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Marton, W. J., & National Nosocomial Infections Surveillance System. (1991). Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1990. Am J Med (suppl, 3B), 86S-89S.
2. Buchaille L., Freydiere A.M., Guinet R., Gille Y. Evaluation of six commercial systems for identification of medically important yeasts. Eur J Clin Microbiol Infect Dis. 17:1998;479-488.
3. Campbell C.K., Davey K.G., Holmes D., Szekely A., Warnock D.W. Comparison of API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J Clin Microbiol. 37:1999;821-823.
4. Davey K.G., Chant P.M., Downer C.S., Campbell C.K., Warnock D.W. Evaluation of the AUXACOLOR system, a new method of clinical yeast identification. J Clin Pathol. 48:1995;807-809.
5. Fricker-Hidalgo H., Lebeau B., Kervroedan P., Faure O., Ambroise-Thomas P., Grillot R. Auxacolor, a new commercial system for yeast identification evaluation of 182 strains comparatively with ID 32C . Ann Biol Clin. 53:1995;221-225.
6. Hantsche D. Differentiation of yeast-like fungi using the commercial Auxacolor system. Mycoses. 39:1996;135-140.
7. Milan E.P., Malheiros E.S., Fischman O., Colombo A.L. Evaluation of the Auxacolor system for the identification of clinical yeast isolates. Mycopath. 137:1997;153-157.
8. Paugam A., Benchetrit M., Fiacre A., Tourte-Schaefer C., Dupouy-Camet J. Comparison of four commercialized biochemical systems for clinical yeast identification by color-producing reactions. Med Mycol. 37:1999;11-17.
9. Sand C., Rennie R.P. Comparison of three commercial systems for the identification of germ-tube negative species isolated from clinical specimens. Diagn Microbiol Infect Dis. 33:1999;223-229.
10. Schuffenecker I., Freydiere A., deMontclos H., Gille Y. Evaluation of four commercial systems for identification of medically important yeasts. Eur J Clin Microbiol Infect Dis. 12:1999;255-260.
11. Sheppard D.C., deSouza E., Hashmi Z., Robson H.G., Rene P. Evaluation of the Auxacolor system for biochemical identification of medically important yeasts. Clin Microbiol. 36:1998;3726-3727.
12. Wingard J.R. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis. 19:(suppl 1):1994;S49-S53.